Mustafa ERTEK, Zülal ÖZKURT, Ayten KADANALI, Serpil EROL, Mehmet PARLAK

Fatal Liver Failure Secondary to Chemotherapy Induced Hepatitis-B Virus Reactivation in a Patient with Acute Myeloid Leukemia

Key Words: Hepatitis B reactivation, lamivudine, acute myeloid leukemia, chemotherapy

Anahtar Kelimeler:

Turk J Med Sci 2005; 35(3): 185-187. Full text: pdf Other articles published in the same issue: Turk J Med Sci, vol.35, iss.3.

Fatal Liver Failure Secondary to Chemotherapy Induced Hepatitis-B Virus Reactivation in a Patient with Acute Myeloid Leukemia

Key Words: Hepatitis B reactivation, lamivudine, acute myeloid leukemia, chemotherapy

Keywords:

Turk J Med Sci 2005; 35(3): 185-187. Full text: pdf Other articles published in the same issue: Turk J Med Sci, vol.35, iss.3.,

PDF

___

1. Rossi G, Pelizzari A, Motta M et al. Primary prophylaxis with lamuvidine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. British Journal of Haematology 115: 58-62, 2001.
2. Yeo W, Chan PKS, Zhong S et al. Frequency of hepatitis B virus reactivation in cancer patient undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. Journal of Medical Virology 62: 299-307, 2000.
3. Xunrong L, Yan AW, Liang R et al. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy, pathogenesis and management. Rev Med Virol 11: 287-99, 2001.
4. Ohtsu T, Sai T, Oka M et al. Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B carriers with hematologic malignancies. Journal of Clinical Oncology 21: 360-5, 1991.
5. Cheng AL. Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin’s lymphoma. Blood 87: 1202, 1996.
6. Al-Taie OH, Mork H, Gassel AM et al. Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature. Ann Hematol 78: 247-91, 1999.
7. Kawai Y, Ikegaya S, Hata M et al. Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin’s lymphoma: case report and review of the literature. Ann Hematol 80: 482-4, 2001.
8. Ahmed A, Keeffe EB. Lamuvidine therapy for chemotherapyinduced reactivation of hepatitis B virus infection. Am J Gastroenterol 94: 249-51, 1999.
9. Saif MW, Little RF, Hamilton JM et al. Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of the literature. Ann Oncol 12: 123-9, 2001.
10. Maguire CM, Crawford DH, Hourigan LF et al. Case report: lamuvidine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy. J Gastroenterol Hepatol 14: 801-4, 1999.
11. Shtalrid M, Haran M, Klepfish A et al. Effective treatment with lamivudine of patients with reactivation of hepatitis B following chemotherapy administration. Harefuah 140: 1159-62, 2001 (Abstract).
12. Clark FL, Drummond MW, Chambers S et al. Successful treatment with lamivudine for fulminant reactivation of hepatitis B infection following intensive therapy for high-grade non-Hodgkin’s lymphoma. Ann Oncol 9: 385-7, 1998.
13. Shibolet O, Ilan Y, Gillis S et al. Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus surface antigen carriers. Blood 100: 391-6, 2002.
14. Lee WC, Wu MJ, Chen CH et al. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipient. Am J Kidney Dis 38: 1074-81, 2001.
15. Stroffolini T, Andriani A, Bibas M et al. Successful treatment with lamuvidine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin’s lymphoma. Ann Hematol 81: 48-9, 2002.
16. Liao CA, Lee CM, Wu HC et al. Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for nonHodgkin’s lymphoma. Br J Haematol 116: 166-9, 2002 (Abstract).
17. Matsuo K, Takenaka K, Shimomura H et al. Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma. Leuk Lymphoma 41: 191-5, 2001 (Abstract).
18. Bozdayi AM, Eyigun CP, Turkyilmaz AR et al. A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil. J Clin Virol 31: 76- 77, 2004.
19. Westland CE, Yang H, Delaney WE et al. Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients. J Viral Hepat 12: 67-73, 2005.
20. Enomoto M, Nishiguchi S, Seki S et al. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin’s lymphoma. Am J Gastroenterol 99: 1619-20, 2004.
21. Marzano A, Lampertico P, Mazzaferro V et al. Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants. Liver Transpl 11: 532-8, 2005.